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CD4+ T cells develop distinct and often contrasting
helper, regulatory, or cytotoxic activities. Typically
a property of CD8+ T cells, granzyme-mediated cyto-
toxic T cell (CTL) potential is also exerted by CD4+
T cells. However, the conditions that induce CD4+
CTLs are not entirely understood. Using single-cell
transcriptional profiling, we uncover a unique signa-
ture of Granzyme B (GzmB)+ CD4+ CTLs, which dis-
tinguishes them from other CD4+ T helper (Th) cells,
including Th1 cells, and strongly contrasts with the
follicular helper T (Tfh) cell signature. The balance be-
tween CD4+ CTL and Tfh differentiation heavily de-
pends on the class of infecting virus and is jointly
regulated by the Tfh-related transcription factors
Bcl6 and Tcf7 (encoding TCF-1) and by the expres-
sion of the inhibitory receptors PD-1 and LAG3.
This unique profile of CD4+ CTLs offers targets for
their study, and its antagonism by the Tfh program
separates CD4+ T cells with either helper or killer
functions.
INTRODUCTION
CD4+ TCRab T cells centrally orchestrate multiple arms of innate
and adaptive immunity using distinct and, often, opposing
effector and regulatory functions through the differentiation of
distinguishable functional CD4+ T cell subsets (O’Shea and
Paul, 2010; Swain et al., 2012; Zhu et al., 2010). Several such
functional subsets are now recognized, including the prototypic
Th1 and Th2 subsets but also the Th17, follicular helper (Tfh), and
regulatory T (Treg) subsets, each characterized by awell-defined
transcriptional program (Crotty, 2014; O’Shea and Paul, 2010;Cell Repo
This is an open access article undSwain et al., 2012; Vinuesa et al., 2016; Zhu et al., 2010). Based
on the increasingly appreciated diversity of CD4+ T cell activities,
additional functional subsets have been proposed. These
include CD4+ with cytotoxic T cell (CTL) potential, able to kill
target cells through the release of granzyme-containing granules
(Brown et al., 2016; Cheroutre and Husain, 2013; Swain et al.,
2012).
Cytotoxicity is typically associated with CD8+ T cells and nat-
ural killer (NK) cells and has not been conventionally considered
a CD4+ T cell function (Cullen et al., 2010). Indeed, ‘‘helper’’ and
‘‘cytotoxic’’ terms are often used to describe the major histo-
compatibility complex (MHC) class-II-restricted CD4+ and
MHC class-I-restricted CD8+ TCRab T cell lineages, respec-
tively. Commitment of developing thymocytes to the CD4+ or
CD8+ lineage and acquisition of either helper or cytotoxic activity
is controlled by the antagonistic transcription factors ThPOK and
Runx3. ThPOK suppresses the cytotoxic program in CD4+ thy-
mocytes and mature T cells, whereas Runx3 promotes this pro-
gram in CD8+ T cells (Cheroutre and Husain, 2013).
Despite transcriptional repression of the cytotoxic program
during CD4+ T cell development, MHC class-II-restricted, cell-
contact-dependent cytotoxicity has long been observed in a va-
riety of conditions, both in humans and experimental animals
(Brown, 2010; Brown et al., 2016; Cheroutre and Husain, 2013;
Soghoian and Streeck, 2010; Swain et al., 2012; van de Berg
et al., 2008). Although CD4+ T cells can kill target cells also
through surface expression of tumor necrosis factor (TNF) family
members, including FasL and TRAIL, accumulated evidence has
established their ability to develop and use granzyme-mediated
cytotoxic activity (Brown et al., 2016; Cheroutre and Husain,
2013). Pivotal recent studies with a ThPOK-reporter mouse
strain uncovered considerable plasticity of the ‘‘helper’’ program
in CD4+ T cells, with loss of ThPOK expression and transcrip-
tional switch to the ‘‘cytotoxic’’ program. Indeed, a sizable frac-
tion of CD4+ T cells residing in the intestine as intraepithelial
lymphocytes (IELs) downregulate the expression of Zbtb7brts 17, 1571–1583, November 1, 2016 ª 2016 The Author(s). 1571
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
(the gene encoding ThPOK) and acquire the expression ofRunx3
(Mucida et al., 2013; Reis et al., 2013). This transcriptional re-
programming is accompanied by the expression of genes
more characteristic of the CD8+ lineage, such as Cd8a, Crtam,
and Eomes, and, importantly, also by the development of
GzmB-mediated cytotoxic potential (Mucida et al., 2013; Reis
et al., 2013).
These studies emphasize the similarities between CD8+ T cells
and reprogrammed CD4+ CTLs and suggest that the latter sub-
set should be viewed as distinct from other CD4+ Th cell subsets
(Cheroutre and Husain, 2013). Despite these significant ad-
vances, the factors that dictate CD4+ CTL differentiation are still
incompletely understood. Also unclear are the precise place of
CD4+ CTLs in the transcriptional spectrum of all Th cell subsets
and whether the CD4+ CTL program is compatible with other Th
cell differentiation pathways.
Here, we investigated the priming requirements for CD4+ CTLs
and the signals that either promote or inhibit CD4+ CTL differen-
tiation. To overcome the lack of a reliable marker for the
unambiguous identification of CD4+ CTLs, we applied global
transcriptional analysis of single CD4+ T cells. We report that
CD4+ CTL differentiation strictly depends on the infecting or
immunizing virus, with retroviral infection and adenovirus-based
vaccination at the low and high ends of the spectrum, respec-
tively. Moreover, our results uncovered regulation of the CD4+
CTL program by expression of inhibitory receptors and direct
antagonism by the Tfh program.
RESULTS
CD4+ CTL Development Depends on Infecting Virus
We have previously described an adoptive transfer system that
allows the study of the CD4+ T cell response to the dominant
H2-Ab-restricted env122–141 epitope within the Friend murine leu-
kemia virus (F-MLV) gp70 glycoprotein (Merkenschlager et al.,
2016; Thorborn et al., 2014). Small numbers of allotypically
marked EF4.1 TCRb-transgenic CD4+ T cells were transferred
into wild-type (WT) C57BL/6 (B6) recipients and primed either
by infection with Friend virus (FV) or by immunization with a hu-
man Adenovirus 5 (Ad5)-based vector expressing F-MLV gp70
(Ad5.pIX-gp70) (Bayer et al., 2010). FV is a retroviral complex
of F-MLV and spleen focus-forming virus (SFFV) that causes
chronic infection in B6 mice (Hasenkrug and Chesebro, 1997;
Tsuji-Kawahara et al., 2013), whereas the Ad5.pIX-gp70 vaccine
vector is replication defective (Bayer et al., 2010). Microarray-
based comparison of EF4.1 env-reactive CD4+ T cells primed
by Ad5.pIX-gp70 indicated elevated transcription of CTL-related
genes, in comparison with T cells primed by FV (Thorborn et al.,
2014). Indeed, on day 7 of the response, env-reactive effector
CD4+ T cells expressed significantly higher amounts of Gzmb
mRNA when primed by Ad5.pIX-gp70 than when primed by FV
(Figure 1A). Moreover, the hosts exhibited significantly higher
levels of MHC class-II-restricted in vivo cytotoxicity against
env122–141-pulsed B cell targets when primed by Ad5.pIX-gp70
than when primed by FV (Figure 1B). More efficient in vivo killing
also correlated with enhanced GzmB-mediated in vitro killing, by
purified env-reactive CD4+ T cells, of B cells loaded with a fluo-
rogenic GzmB substrate (Figure 1C).1572 Cell Reports 17, 1571–1583, November 1, 2016Consistent with higherGzmb expression and GzmB-mediated
killing at the population level, env-reactive effector CD4+ T cells
contained a significantly higher proportion of GzmB+ cells if
primed by Ad5.pIX-gp70 than if primed by FV (Figure 1D).
Notably, GzmB protein expression was detected in env-reactive
effector CD4+ T cells even without in vitro restimulation (Fig-
ure S1A), suggesting that it reflected in-vivo-induced production.
Moreover, EF4.1 env-reactive CD4+ T cells, additionally carrying
an allele encoding a fusion of GzmB and tdTomato fluorescent
protein (Mouchacca et al., 2013), contained a significantly higher
frequency of GzmB-tdTomato+ cells when primed by Ad5.pIX-
gp70 than when primed by FV (Figure S1B). Together, these
data support the idea that GzmB production was induced in vivo
in splenic CD4+ T cells during Ad5.pIX-gp70 immunization.
Furthermore, Ad5.pIX-gp70 vaccination induced a significantly
higher frequency of GzmB+ cells in splenic host effector
CD44+IFN-g+CD8+ T cells than FV infection did (Figure S2),
arguing that the difference between the two immunogens was
not restricted to CD4+ T cells or to TCR (T cell-receptor)-trans-
genic T cells.
One notable difference between FV infection and Ad5.pIX-
gp70 immunization is their ability to prime different TCR clono-
types (Thorborn et al., 2014). EF4.1 env-reactive CD4+ T cells
induced by FV are primarily TCR Va2+, whereas those induced
by Ad5.pIX-gp70 express amember of the TCR Va3 family (Thor-
born et al., 2014). Differences in TCR usage could underlie the
distinct ability of FV and Ad5.pIX-gp70 to induce CD4+ CTLs.
Indeed, differentiation of GzmB+ CD4+ T cells was moderately
higher in Va3+ than the Va2+ fraction of FV-primed env-reactive
CD4+ T cells (Figures S3A and S3B). Nevertheless, the two frac-
tions differentiated into GzmB+ CD4+ T cells with comparable
efficiency upon Ad5.pIX-gp70 immunization (Figures S3A and
S3B). Moreover, Ad5.pIX-gp70 induced significantly stronger
Gzmb expression in monoclonal TCR-transgenic EVa2 CD4+
T cells than FV infection did (Figure S3C). These results indicated
a small effect of TCR usage on CD4+ CTL differentiation, which
was, however, overshadowed by other properties of the two
viruses.
Lastly, different immunization regimens elicited distinct fre-
quencies of GzmB+ cells within env-reactive effector CD4+
T cells (Figure 1E). These included non-persisting infection with
attenuated N-tropic F-MLV (F-MLV-N) (Dittmer et al., 1998) or
transient env124–138 peptide immunization, which failed to induce
GzmB+ cells, and transplantation of the FV-induced FBL-3 tumor
cell line (Klarnet et al., 1989), which induced moderate levels of
GzmB+ cells (Figure 1E). They also included infection with a
replication-competent and persisting mouse-cytomegalovirus
(mCMV)-based vector encoding F-MLV env, which also induced
readily detectable GzmB+ cells (Figure 1E). Thus, properties of
the infecting or immunizing virus, independently of its ability to
persist in the host, largely determine the efficiency of antigen-
specific CD4+ T cell differentiation into CTLs, with Ad5.pIX-
gp70 outperforming FV.
Antagonistic CD4+ CTL and Tfh Development
Both TCR usage and the nature of infecting virus can heavily in-
fluence Th subset differentiation, which is reflected in the corre-
sponding transcriptional profiles. The necessary cell processing
Figure 1. CD4+ CTL Development Depends on Infecting Virus
(A) Expression ofGzmb, relative to Hprt, assessed by qRT-PCR in env-reactive donor EF4.1 CD4+ T cells purified from the spleens of recipient mice, 7 days after
adoptive transfer and FV infection or Ad5.pIX-gp70 immunization. Plotted are the mean values (±SEM) of four technical replicates, from two experiments with five
mice per group per experiment.
(B) Flow-cytometric detection (left) and efficiency of in vivo killing (right) of env122–141-pulsed CD45.1
+ and non-pulsed CD45.2+ B cells in host splenocytes, 24 hr
after transfer into CD45.1+CD45.2+ hosts (53 106 of each per host) that had also received EF4.1 CD4+ T cells and had either been infected with FV or immunized
with Ad5.pIX-gp70 7 days earlier.
(C) Flow-cytometric detection (left) and efficiency of in vitro killing (right) of env122–141-pulsed and non-pulsed B cells, 2 hr after culture with env-reactive donor
EF4.1 CD4+ T cells purified from the spleens of recipient mice, 7 days after adoptive transfer and FV infection or Ad5.pIX-gp70 immunization.
(D) Flow-cytometric detection of intracellular GzmB host naive (CD44) or env-reactive (CD44+) donor EF4.1 CD4+ T cells (left) and frequency of GzmB+ cells in
env-reactive donor EF4.1 CD4+ T cells (right) in the spleens of recipient mice, 7 days after adoptive transfer and FV infection or Ad5.pIX-gp70 immunization.
(E) Frequency of intracellular GzmB+ cells in env-reactive donor EF4.1 CD4+ T cells in the spleens of recipient mice, 7 days after adoptive transfer and FV infection,
F-MLV-N infection, env122–141 peptide immunization in the Sigma Adjuvant System, FBL-3 leukemia cell transplantation, mCMV.env infection, or Ad5.pIX-gp70
immunization.
In (B) to (E), each symbol in the scatterplots represents an individual recipient mouse.
See also Figures S1, S2, and S3.for intracellular GzmB staining precluded further transcriptional
analysis between GzmB+ and GzmB CD4+ T cells. To over-
come this limitation, we performed single-cell RNA sequencing
of env-specific CD4+ T cells primed either by FV or Ad5.pIX-
gp70. Consistent with flow-cytometric detection of GzmB pro-
duction, FV induced Gzmb expression in 3/57 and 1/65 cells
(an average of 3.2%), whereas Ad5.pIX-gp70 induced Gzmb
expression in 6/42 and 4/45 cells (an average of 11.5%) analyzed
in two independent runs (p = 0.022, Fisher’s exact test) (Fig-
ure 2A). In contrast, expression of other cytotoxic mediators,such as Tnfa, Fasl, and Tnfsf10, was comparable between FV
and Ad5.pIX-gp70 priming (Figure S4). It should be noted that
gene expression assessment by single-cell RNA sequencing
represents the lower limit, as it captures only a fraction of the
genes expressed in a given cell. This is evident in the transcrip-
tion of the Cd4 gene, which is not detected in all of the CD4+
T cells analyzed (Figure 2A).
Single-cell transcriptional analysis revealed another notable
difference between FV-primed and Ad5.pIX-gp70-primed CD4+
T cells: a significantly higher proportion of the former transcribedCell Reports 17, 1571–1583, November 1, 2016 1573
Figure 2. Antagonistic CD4+ CTL and Tfh Development
(A) Cd4 and Gzmb expression, assessed by single-cell RNA sequencing, in env-reactive donor EF4.1 CD4+ T cells purified from the spleens of recipient mice,
7 days after adoptive transfer and FV infection or Ad5.pIX-gp70 immunization. Each symbol shows the log2-transformed normalized reads from an individual cell
from one of two experiments. Numbers within the plots denote the number of cells positive for expression of the indicated gene.
(B) Tcf7 and Bcl6 expression in the same cells as in (A).
(C) Expression of Tcf7 and Bcl6, relative toHprt, assessed by qRT-PCR in bulk env-reactive donor EF4.1 CD4+ T cells purified from the spleens of recipient mice,
7 days after adoptive transfer and FV infection or Ad5.pIX-gp70 immunization. Plotted are the mean values (±SEM) of four technical replicates from two
experiments with four mice per group per experiment.
(D) Heatmap of gene expression, assessed by single-cell RNA sequencing, comparing Gzmb+ and Gzmb subsets in env-reactive donor EF4.1 CD4+ T cells
purified from the spleens of recipient mice, 7 days after adoptive transfer and priming. CD4+ T cells from both FV infection and Ad5.pIX-gp70 immunization are
included. A select set of genes from the complete list in Table S1 is shown.
(E) Flow-cytometric correlation of intracellular GzmB and surface markers CXCR6, CD39, CD150, and CD226 (left) and frequency of surface marker+ cells
separately in GzmB and GzmB+ cells within env-reactive (CD44+) donor EF4.1 CD4+ T cells (right) in the spleens of recipient mice, 7 days after adoptive transfer
and Ad5.pIX-gp70 immunization. In the scatterplots, each symbol represents an individual recipient.
(F) Expression of Prdm1, Bcl6, Lef1, Tcf7, Zbtb7b, and Runx3 assessed by single-cell RNA sequencing, separately in Gzmb+ and Gzmb env-reactive donor
EF4.1 CD4+ T cells purified from the spleens of recipient mice, 7 days after adoptive transfer and Ad5.pIX-gp70 immunization.
See also Figures S4, S5, and S6 and Table S1.
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Bcl6 (p = 0.025, Fisher’s exact test) (Figure 2B), which is essential
for Tfh development (Crotty, 2014; Vinuesa et al., 2016). In
contrast, the two types of CD4+ T cells displayed comparable
transcription ofTcf7 (Figure 2B), encoding the transcription factor
TCF-1, which has been recently found to promote Tfh develop-
ment at multiple levels, including through induction of Bcl6
transcription (Choi et al., 2015; Wu et al., 2015; Xu et al., 2015).
Independently assessed in CD4+ T cell populations, levels of
Tcf7 were not significantly lower in Ad5.pIX-gp70-primed than
in FV-primed CD4+ T cells, whereas levels of Bcl6 were (Fig-
ure 2C). Together, these results suggested that the degree of
CTL and Tfh differentiation in env-specific CD4+ T cells are
inversely correlated and dictated by the priming virus.
To examine whether CTL differentiation was inhibited by
competing Th programs, we compared the gene transcripts
that distinguished Gzmb+ cells (Table S1). Interestingly, Gzmb+
cells primed by either virus were characterized by specific loss
of Tcf7 expression, among a selected set of genes (Figure 2D).
Conversely,Gzmb+ cells were characterized by elevated expres-
sion of several other genes, including Cxcr6, Entpd1 (encoding
CD39), Slamf1 (encoding CD150), and Cd226 (Figure 2D), which
were further validated by flow cytometry (Figure 2E). These tran-
scriptional differences were also significant when Gzmb and
Gzmb+ cells primed by Ad5.pIX-gp70 only were analyzed (Fig-
ure S5). Accordingly, none of the Ad5.pIX-gp70-primed Gzmb+
cells expressed Bcl6, and half of them expressed the antago-
nistic transcription factor Blimp-1, encoded by Prdm1, in sharp
contrast to Gzmb cells (Figure 2F). Also in contrast to Gzmb
cells, which were nearly all Tcf7+ and most also expressed
Lef1, encoding the TCF-1 homolog LEF-1, Gzmb+ cells only
sporadically expressed Tcf7 and Lef1 (Figure 2F; Figure S6A).
The balance of Zbtb7b (encoding ThPOK) and Runx3 tran-
scription, associated with the CD4+ and CD8+ lineages, respec-
tively (Cheroutre and Husain, 2013), was also altered in Ad5.pIX-
gp70-primed Gzmb+ T cells (Figure 2F; Figure S6A). This
observation is consistent with previous reports on intestinal
CD4+ CTLs, in which Runx3 expression is associated with
CD8a expression (Mucida et al., 2013; Reis et al., 2013). In
contrast to intestinal CD4+ CTLs, however, the altered balance
of Zbtb7b and Runx3 transcription in splenic Gzmb+ CD4+
T cells induced by Ad5.pIX-gp70 did not lead to transcription
of either the Cd8a or Cd8b1 genes or the acquisition of Crtam
or Eomes expression (Figure S6B). Lastly, transcription of Cd5
and Nr4a1 (encoding Nur77), which could be indicative of the
strength of TCR signaling experienced by env-specific CD4+
T cells, did not significantly differ between Gzmb and Gzmb+
cells (Figure S6C), suggesting that TCR signal strength is not
the primary determinant of CD4+ CTL differentiation. Collec-
tively, these findings point to a CD4+ CTL-specific transcriptional
signature, characterized by acquisition of Runx3 transcription
and, importantly, downregulation of Tfh-related transcription,
particularly of Tcf7.
Bcl6 Suppresses CD4+ CTL Development
Loss of Tfh-specific transcription in Gzmb+ CD4+ T cells sug-
gested that the TCF-1–Bcl6 nexus was incompatible with, or
actively inhibiting, CD4+ CTL differentiation. To test this possibil-
ity, we used conditional ablation of Bcl6 in env-specific effectorCD4+ T cells, which were transferred into WT hosts (Figure S7).
This was achieved by expression of Cre in donor CD4+ T cells un-
der the control of the Tnfrsf4 promoter (Tnfrsf4Cre) (Klinger et al.,
2009). This promoter activates in the majority of CD4+ T cells,
only following antigen recognition, thus avoiding any effects of
gene deletion during T cell development and prior to activation
(Marques et al., 2009). Effector CD4+ T cells that activated the
Tnfrsf4 promoter were identified using a Cre-conditional yellow
fluorescent protein (YFP) reporter (Gt(ROSA)26SorYFP) allele.
A Cre-conditional Bcl6 (Bcl6fl) allele (Kaji et al., 2012) was also
introduced in separate donor EF4.1 mice. These combinations
created four separate populations of env-specific donor CD4+
T cells (Figure 3A; Figure S7). Particularly, YFP CD4+ T cells
with (Bcl6fl) or without the conditional Bcl6 allele (Bcl6wt) would
be comparable, as they retained the capacity to express Bcl6,
whereas YFP+ Bcl6fl, but not Bcl6wt, CD4+ T cells would lose
this capacity (Merkenschlager et al., 2016).
Transcriptional analysis of env-specific donor CD4+ T cell pop-
ulations primed by either virus confirmed significantly higher
Bcl6 expression in FV-primed than in Ad5.pIX-gp70-primed
T cells, regardless of Tnfrsf4 promoter activity (Figure 3B). More-
over, Bcl6 expression was lost in the YFP+, but not the YFP,
fraction of Bcl6fl T cells (Figure 3B), validating the approach.
Loss of Bcl6 expression in the YFP+ fraction was accompanied
by significant gain in expression of Prdm1, as well as of Gata3,
Tbx21, and Ifng (Figure 3B), but not of Foxp3 or Rorc (Figure S8),
suggesting that Bcl6 was suppressing the Th1 and Th2 pro-
grams. This effect of Bcl6 deletion on CD4+ T cell differentiation
was further confirmed by intracellular staining for T-bet (encoded
by Tbx21) and interferon (IFN)-g (Figure S9). Higher levels of
T-bet and IFN-g were induced by FV infection than Ad5.pIX-
gp70 immunization in Bcl6wt CD4+ T cells, and these were not
further elevated in Bcl6fl CD4+ T cells (Figure S9). In contrast,
the low levels of T-bet and IFN-g induced by Ad5.pIX-gp70 im-
munization in Bcl6wt CD4+ T cells were significantly elevated in
Bcl6fl CD4+ T cells (Figure S9).
In addition to enhancing differentiation of other Th cell sub-
sets, loss of Bcl6 expression led to a striking upregulation of
Gzmb transcription, specifically in Ad5.pIX-gp70-primed CD4+
T cells (Figure 3B). Importantly, the gain in Gzmb expression in
the latter population (>13-fold) was considerably more pro-
nounced than the gain in the transcription of the other genes
examined (2.2- to 3.8-fold) (Figure 3B). The significantly height-
ened transcription of Gzmb, specifically in Ad5.pIX-gp70 immu-
nization, was additionally confirmed by intracellular staining for
GzmB in the total env-specificBcl6fl CD4+ T cell population, con-
taining both Bcl6-deleted and non-deleted cells (Figure 4A).
To gain better insight into the transcriptional profile of only the
Bcl6-deleted env-specific CD4+ T cells, without the need for
in vitro restimulation, we next subjected the purified YFP+ frac-
tion of Bcl6fl CD4+ T cells to single-cell RNA sequencing. This
analysis demonstrated a significant increase in the frequency
of Gzmb+ cells in Bcl6-deleted env-specific CD4+ T cells
following priming by Ad5.pIX-gp70 (Figure 4B). Indeed, nearly
40%of these cells were positive forGzmb transcripts (Figure 4B).
In contrast, the frequency of Gzmb+ cells in Bcl6-deleted env-
specific CD4+ T cells primed by FV did not change significantly
(Figures 2A and 4B). These data with Bcl6-deleted populationsCell Reports 17, 1571–1583, November 1, 2016 1575
Figure 3. Bcl6 Suppresses CD4+ CTLDevelopment at the Population
Level
(A) Delineation of env-reactive donor EF4.1 CD4+ T cells according to YFP
expression. Histograms show gated env-reactive EF4.1 CD4+ T cells from
Bcl6wt or Bcl6fl donors, found in the spleens of recipient mice, 7 days after
adoptive transfer and FV infection or Ad5.pIX-gp70 immunization. YFP
expression reports activation of the Tnfrsf4 gene and, in the case of Bcl6fl
donor CD4+ T cells, also loss of Bcl6. Numbers within the plots denote the
proportion of YFP+ cells.
(B) Expression of the indicated gene, relative toHprt, assessed by qRT-PCR in
the respective bulk subset of env-reactive donor EF4.1 CD4+ T cells shown
immediately above in (A). Plotted are the mean values (±SEM) of two technical
replicates, from two experiments with five mice per group per experiment.
See also Figures S7, S8, and S9.
1576 Cell Reports 17, 1571–1583, November 1, 2016and purified single cells suggested that Bcl6 was restraining
the CTL program in env-specific CD4+ T cells, at least during
Ad5.pIX-gp70 priming.
To relate the effect of Bcl6 deletion on Gzmb expression, we
examined the transcription of additional effector molecules in
single WT or Bcl6-deleted env-specific CD4+ T cells. A high pro-
portion (68%) of WT CD4+ T cells primed by FV expressed Il21
(which, in these settings, was characteristic of the Tfh response),
and a smaller proportion (14%) expressed Il10, with only partial
overlap with Ifng expression (Figure 4C). Although loss of Bcl6
during FV infection did not markedly reduce Il21 expression, it
did significantly enhance expression of both Ifng (2.3-fold) and
Il10 (4.7-fold), which were now co-expressed in the majority of
Bcl6-deleted CD4+ T cells (Figure 4C). In stark contrast to FV
infection, Ad5.pIX-gp70 immunization induced very little Il21 or
Il10 expression in either WT or Bcl6-deleted env-specific CD4+
T cells (Figure 4C). Moreover, Bcl6 deletion induced a more
modest gain in Ifng-expressing cells (1.5-fold) after Ad5.pIX-
gp70 priming than after FV priming (Figure 4C). Collectively,
these data argued that Bcl6 suppressed specifically CTL differ-
entiation of env-specific CD4+ T cells during Ad5.pIX-gp70
priming.
CD4+ CTL and Th1 Cells Are Transcriptionally Distinct
GzmB expression is often considered a part of the Th1 program
of CD4+ T cell differentiation. Indeed, some of the genes, such as
Slamf1 (encoding CD150), whose expression characterized
Gzmb+ cells (Figures 2D and 2E), are also used to distinguish
Th1 from Tfh cells (Crotty, 2014; Vinuesa et al., 2016). Single-
cell transcriptional analysis revealed that, independently of
priming virus or Bcl6 sufficiency, over half (57%) of Gzmb+ cells
co-expressed Ifng (Figure 5A). Similar results were obtained at
the protein level (Figure 5B), indicating a close relationship be-
tween GzmB and IFN-g production. However, the strong Ifng
expression in FV infection without concomitant Gzmb expres-
sion, and the inverse during Ad5.pIX-gp70 immunization, partic-
ularly after loss of Bcl6 (Figures 3B, 4A, and 4C), suggested that
the profiles of Th1 cells and those that additionally display CTL
potential may be separable, both qualitatively and quantitatively.
For example, although both Th1 cells and Th1 cells with CTL po-
tential expressed CD150 (encoded by Slamf1), a direct compar-
ison of IFN-g+ env-specific CD4+ T cells that co-produced GzmB
(IFN-g+GzmB+) with those that did not (IFN-g+GzmB) revealed
significantly higher CD150 expression in the former (Figure 5C).
To comprehensively explore potential transcriptional differ-
ences between Th1 and CTL CD4+ T cells, we compared the
transcriptional profiles of env-specific CD4+ T cells expressing
Ifng, but not Gzmb (Ifng+Gzmb), and those co-expressing Ifng
and Gzmb (Ifng+Gzmb+). We reasoned that restricting this com-
parison only to cells expressing Ifngwould minimize the effect of
comparing mixed Th functional subsets and emphasize differ-
ences correlating with Gzmb production. Despite common Ifng
expression, the transcriptional profile of Ifng+Gzmb+ cells was
readily distinguishable from that of Ifng+Gzmb cells (Fig-
ure 5D). The transcriptional difference between Ifng+Gzmb+
and Ifng+Gzmb cells remained significant when Ad5.pIX-gp70
priming was analyzed separately, whereas it narrowly lost signif-
icance when FV priming was analyzed in isolation due to the low
Figure 4. Bcl6 Suppresses CD4+ CTL Devel-
opment at the Single-Cell Level
(A) Frequency of intracellular GzmB+ cells in bulk
Bcl6wt or Bcl6fl env-reactive donor EF4.1 CD4+
T cells in the spleens of recipient mice, 7 days after
adoptive transfer and FV infection or Ad5.pIX-
gp70 immunization. Each symbol represents an
individual mouse from one representative of two
experiments.
(B)Cd4 andGzmb expression, assessed by single-
cell RNA sequencing, in YFP+ Bcl6fl env-reactive
donor EF4.1 CD4+ T cells purified from the spleens
of recipient mice, 7 days after adoptive transfer
and FV infection or Ad5.pIX-gp70 immunization.
(C) Il21, Il10, and Ifng expression, assessed by
single-cell RNA sequencing, in YFP+ Bcl6wt, and
Bcl6fl env-reactive donor EF4.1 CD4+ T cells puri-
fied from the spleens of recipient mice, 7 days after
adoptive transfer and FV infection or Ad5.pIX-gp70
immunization.number of Gzmb+ cells induced by FV (Figure S10). Moreover,
Ifng+Gzmb+ and Ifng+Gzmb cells remained transcriptionally
significantly distinct when Tfh cells were excluded from the anal-
ysis, either by virtue of Cxcr5 expression or by limiting the anal-
ysis to Bcl6-deleted CD4+ T cells, which cannot differentiate into
Tfh cells (Figure S11).
Importantly, the transcriptional differences between Ifng+
Gzmb+ and Ifng+Gzmb- cells (Figure 5D) largely overlapped
with those characterizing the Gzmb+ subset as a whole (Fig-
ure 2D). This was particularly evident in the opposing expression
of Prdm1 and Tcf7. Indeed, whereas most Ifng+Gzmb cells ex-
pressed Tcf7 but not Prdm1, most Ifng+Gzmb+ cells expressed
Prdm1 but not Tcf7 (Figure 5E), suggesting that the combination
of these two markers was sufficient to distinguish between the
Th1 and CD4+ CTLs.
To confirm the distinguishing pattern of Prdm1 and Tcf7
expression of Gzmb+ CD4+ T cells, we used EF4.1 TCRb-trans-
genic CD4+ T cells additionally carrying a GFP reporter into the
Prdm1 locus (Kallies et al., 2009). As GFP insertion disrupts the
Prdm1 gene in these mice (Kallies et al., 2009), we used donors
heterozygous for the Prdm1Gfp allele to prevent loss of function
of the encoded Blimp1 in the adoptively transferred CD4+
T cells. Following Ad5.pIX-gp70 immunization, a small propor-
tion (8%) of donor env-specific effector CD4+ T cells displayed
Blimp1-GFP expression (Figure 5F) and contained Prdm1 tran-
scripts (Figure 5G). Notably, this fraction was also characterized
by paucity of Tcf7 and overabundance ofGzmb transcripts, rela-
tive to the Blimp1-GFP fraction (Figure 5G). Thus, loss of Tcf7
expression and induction of Prdm1 expression could differen-Cell Repotiate Gzmb+ CD4+ T cells from other Th
subsets, including Th1 cells.
Layered Checkpoints in CD4+ CTL
Development
Our findings supported a role for Bcl6
in restraining CD4+ CTL development,
particularly of CD4+ T cells respondingto Ad5.pIX-gp70 immunization (Figures 3 and 4). However, in
response to FV infection, Bcl6 ablation in env-specific CD4+
T cells failed to promote CD4+ CTL differentiation, despite
elevated Prdm1 expression (Figure 3). Therefore, we hypothe-
sized that additional layers of regulation were limiting CD4+
CTL differentiation specifically in FV infection. To test this idea,
we compared the expression of inhibitory receptors in env-spe-
cific CD4+ T cells primed by either FV or Ad5.pIX-gp70. Following
FV infection, the majority (>65%) of Gzmb cells co-expressed
Pcdc1 (encoding PD-1), Lag3, and Ctla4 but completely lacked
expression of Havcr2 (encoding Tim-3) (Figure 6A). By compari-
son, following Ad5.pIX-gp70 immunization, Ctla4 expression
was comparable in Gzmb cells, but expression of Pcdc1 was
reduced to 36%, and expression of Lag3was now largely absent
(8%) (Figure 6A). Notably, the difference in expression of inhibi-
tory receptors between the two viruses was more pronounced
in Gzmb+ cells, which, in the case of FV priming, co-expressed
all four inhibitory receptors (Figure 6A). In contrast, Gzmb+ cells
primed by Ad5.pIX-gp70 lacked expression of Pcdc1 and Lag3
(Figure 6A). This difference between the two viruses in the induc-
tion of Pcdc1 and Lag3 expression was also confirmed at the
PD-1 and LAG3 protein level. Consistent with the RNA expres-
sion data, PD-1 was expressed by nearly all env-specific CD4+
T cells, but at significantly higher levels in FV infection than in
Ad5.pIX-gp70 immunization (Figures 6B and 6C). Similarly, a
much larger fraction of env-specific CD4+ T cells exhibited
LAG3 surface expression when primed by FV than by Ad5.pIX-
gp70 (Figure 6B), a difference that was also reflected in the inten-
sity of LAG3 staining of the entire population (Figure 6C). Thus,rts 17, 1571–1583, November 1, 2016 1577
Figure 5. CD4+ CTL and Th1 Cells Are Tran-
scriptionally Distinct
(A)Gzmb and Ifng expression, assessed by single-
cell RNA sequencing, in env-reactive donor EF4.1
CD4+ T cells purified from the spleens of recipient
mice, 7 days after adoptive transfer and priming.
Both Bcl6wt and Bcl6fl CD4+ T cells from both
FV infection and Ad5.pIX-gp70 immunization are
included.
(B) Flow-cytometric detection of intracellular
GzmB and IFN-g in host naive (CD44) or env-
reactive (CD44+) donor EF4.1 CD4+ T cells in the
spleens of recipient mice, 7 days after adoptive
transfer and Ad5.pIX-gp70 immunization. The plot
is representative of four recipients.
(C) Flow-cytometric correlation of intracellular
GzmB and surface CD150 expression (left) and
frequency of CD150+ cells separately in GzmB
and GzmB+ cells within IFN-g+ env-reactive
(CD44+) donor EF4.1 CD4+ T cells (right) in the
spleens of recipient mice, 7 days after adoptive
transfer and Ad5.pIX-gp70 immunization. In the
scatterplot, each symbol represents an individual
recipient.
(D) Heatmap of significantly (p = 3.95 3 104)
regulated gene expression, assessed by single-
cell RNA sequencing, comparing Ifng+Gzmb+ and
Ifng+Gzmb subsets in the same cells as in (A).
(E) Prdm1 and Tcf7 expression, assessed by
single-cell RNA sequencing, in the same cells
as in (A).
(F) Flow-cytometric detection of Blimp1-GFP and
CD44 expression in host and env-reactive donor
CD4+ T cells in the spleens of recipient mice,
7 days after adoptive transfer and Ad5.pIX-gp70
immunization.
(G) Expression of Prdm1, Tcf7, andGzmb, relative
to Hprt, assessed by qRT-PCR in bulk Blimp1-
GFP+ and Blimp1-GFP- subsets in env-reactive donor EF4.1 CD4+ T cells purified from the spleens of recipient mice, 7 days after adoptive transfer and Ad5.pIX-
gp70 immunization. Plotted are the mean values (±SEM) of two technical replicates from one experiment with five mice per group.
See also Figures S10 and S11.Gzmb+ cells displayed considerable expression of Ctla4 and
exclusive expression of Havcr2, regardless of the priming virus.
Indeed, Havcr2 expression also distinguished Ifng+Gzmb+ cells
from Ifng+Gzmb cells (Figure 5C). In contrast, significant
expression of both Pcdc1 and Lag3 was induced in Gzmb+
env-specific CD4+ T cells uniquely by FV infection but not
Ad5.pIX-gp70 immunization.
The pattern of inhibitory receptors expressed by FV-primed
env-specific CD4+ T cells was suggestive of an exhausted
phenotype (Crawford et al., 2014), which was investigated
further. PD-1 expression was more consistent with antigen-
induced activation of effector CD4+ T cells than with cellular
exhaustion, as it was also induced by Ad5.pIX-gp70, albeit to a
lower intensity per cell (Figure 6C), and was also substantially
reduced quickly after the peak of the effector response to FV
infection (Figure S12). Moreover, effector CD4+ T cells isolated
from acute FV infection were transcriptionally distinct from
typical exhausted CD4+ T cells isolated from chronic lympho-
cytic choriomeningitis virus (LCMV) infection (Crawford et al.,
2014; Figure S13A), suggesting that expression of inhibitory re-
ceptors by FV-primed effector CD4+ T cells was part of acute1578 Cell Reports 17, 1571–1583, November 1, 2016effector differentiation rather than of the exhaustion that charac-
terizes chronic viral infections.
Nevertheless, expression of inhibitory receptors, particularly
of PD-1 and LAG3, by env-specific CD4+ T cells during acute
FV infection could still influence cellular activation or CTL differ-
entiation. To this end, we treated WT recipients of env-specific
CD4+ T cells with PD-1- and LAG3-blocking antibodies during
the course of FV infection. Although blockade of either PD-1 or
LAG3 separately had only a modest effect, the combined PD-1
and LAG3 blockade significantly increased in the frequency of
Gzmb+ cells in donor CD4+ T cells (Figure 6D; Figure S14), sup-
porting their role in restraining CD4+ CTL differentiation. In
contrast, the PD-1 and LAG3 blockade did not appreciably alter
clonal expansion of donor CD4+ T cells or their production of
IFN-g and TNF-a (Figure S15).
The high levels of PD-1 expression in env-specific CD4+ T cells
responding to FV infection were previously shown to require
cognate interaction between T cells and B cells (Ploquin et al.,
2011). Therefore, we used B cell deficiency as an alternative to
PD-1 blockade. Indeed, a significantly higher proportion of
env-specific CD4+ T cells expressed intracellular GzmB when
Figure 6. Layered Checkpoints in CD4+ CTL
Development
(A) Pcdc1, Lag3, Ctla4, and Havcr2 expression,
assessed by single-cell RNA sequencing, in env-
reactive donor EF4.1 CD4+ T cells purified from the
spleens of recipient mice, 7 days after adoptive
transfer and FV infection or Ad5.pIX-gp70 immuni-
zation. Both Bcl6wt and Bcl6fl CD4+ T cells are
included.
(B) Flow-cytometric detection of PD-1 and LAG3
expression in host naive (CD44) and env-reactive
(CD44+) donor CD4+ T cells in the spleens of
recipient mice, 7 days after adoptive transfer
and FV infection or Ad5.pIX-gp70 immunization.
Numbers within the plots denote the proportion of
PD-1+ and LAG3+ cells in env-reactive donor CD4+
T cells only.
(C) Median fluorescence intensity (MFI) of PD-1 and
LAG3 staining in the same cells as in (B). Each
symbol represents an individual recipient. The
dashed line represents the MFI of PD-1 and LAG3
staining in host naive CD4+ T cells.
(D) Frequency of intracellular GzmB+ cells in bulk
Bcl6wt and Bcl6fl env-reactive donor EF4.1 CD4+
T cells in the spleens of either WT or B cell-deficient
Ighm/ recipient mice, 7 days after adoptive
transfer and FV infection. The indicated groups
additionally received treatment with PD-1- and
LAG3-blocking antibodies. Each symbol represents
an individual recipient.
See also Figures S12, S13, S14, and S15.transferred into B cell-deficient Ighm/ hosts than intoWT hosts
(Figure 6D). These findings supported the premise that PD-1 and
LAG3 posed a further block in CD4+ CTL differentiation, in addi-
tion to Bcl6 expression. To test this premise directly, we com-
bined Bcl6 deficiency in env-specific CD4+ T cells with PD-1
and LAG3 blockade. As before (Figure 4A), Bcl6 deficiency alone
did not significantly enhance CD4+ CTL differentiation during FV
infection (Figure 6D). In contrast, the combination of Bcl6 defi-
ciency and PD-1 and LAG3 blockade markedly increased the
proportion of Gzmb+ cells (3-fold) (Figure 6D) to levels compa-
rable with those induced by Bcl6 deficiency in Ad5.pIX-gp70 im-
munization (Figure 4B). Thus, PD-1 and LAG3 were preventing
Bcl6-deficient env-specific CD4+ T cells from acquiring GzmB
expression during FV infection, representing an additional level
of CD4+ CTL differentiation control.Cell RepoDISCUSSION
Since the earliest descriptions of MHC
class-II-restricted cytotoxic activity in
CD4+ T cells nearly 4 decades ago, a num-
ber of studies have implicated CD4+ CTLs
in antiviral and antitumor immunity, as well
as in autoimmune and inflammatory condi-
tions (Brown, 2010; Brown et al., 2016;
Cheroutre and Husain, 2013; Soghoian
and Streeck, 2010; van de Berg et al.,
2008). Nevertheless, the priming require-
ments for CD4+ CTLs or their phenotypicoverlap with other CD4+ Th subsets have only recently begun
to emerge. Here, we described the transcriptional profile of
CD4+ CTLs as the antipode of the Tfh profile. We provided evi-
dence to suggest multilayered control of CD4+ CTL differentia-
tion: first, by the TCF-1–Bcl6 nexus driving Tfh polarization,
and second, inhibition by PD-1 and LAG3.
Study of CD4+ CTLs has been hampered by the lack of distinc-
tive markers that are compatible with further characterization of
these cells. Although MHC class-II-restricted cytotoxic activity
has been amply documented, it has not been consistently attrib-
uted to granzyme-mediated killing, as opposed to killing medi-
ated by secreted or membrane-bound cytokines, including
IFN-g, expressed by Th1 cells, ormembers of the TNF family, ex-
pressed by multiple CD4+ Th cell subsets (Brown et al., 2016;
Cheroutre and Husain, 2013). Even when production of GzmBrts 17, 1571–1583, November 1, 2016 1579
was used for the identification of CD4+ CTLs, a certain degree of
phenotypic overlap with Th1 cells was noted (Hua et al., 2013),
and indeed, GzmB-producing CD4+ T cells are still regarded in
the literature as a variant of the Th1 subset. This view is further
supported by a potential developmental connection between
CD4+ CTLs and Th1 cells (Cheroutre and Husain, 2013).
Indeed, GzmB-producing cells often also express typical Th1
products, including IFN-g. CD4+ CTL differentiation, particularly
in response to interleukin-2 (IL-2) and IFN-a stimulation, has also
been suggested to rely on the Th1-related transcription factor
T-bet (encoded by the Tbx21 gene), which can bind directly to
theGzmb promoter (Hua et al., 2013). However, CD4+ CTL differ-
entiation has been reported in other studies to depend not on
T-bet but on its homolog Eomesodermin (encoded by the Eomes
gene) (Hirschhorn-Cymerman et al., 2012; Qui et al., 2011). The
differential dependency on either T-bet or Eomesodermin may
indicate that, depending on the priming conditions, CD4+ CTLs
can develop through separate developmental pathways, which
may or may not overlap with the Th1 differentiation pathway. Us-
ing a single-cell RNA-sequencing approach, we were able to
contrast the entire transcriptome of Gzmb+ CD4+ T cells with
that of other CD4+ T cells, without prior assumptions of their tran-
scriptional overlap. This approach did not support a correlation
between expression of Gzmb and expression of either Tbx21
or Eomes, suggesting a certain degree of redundancy. It did,
however, reveal a clear distinction between CD4+ T cells with
CTL potential and Th1 cells, exemplified in the reciprocal expres-
sion of Tcf7 and Prdm1. Although CD4+ CTLs are more similar to
the Th1 than other Th subsets, loss of Tcf7 expression and
concomitant gain of Prdm1 expression in CD4+ CTLs set them
apart from all other Th subsets, including Th1 cells. Equally
unique was the expression of Havcr2 (encoding Tim-3), which
was found exclusively in CD4+ CTLs.
Although our results uncover prominent transcriptional differ-
ences between CD4+ CTLs and Th1 cells, they do not currently
inform on any lineage or precursor-product relationship between
the two. CD4+ CTLs may represent an advanced or divergent
state of Th1 differentiation, characterized by loss of Tcf7 and
acquisition of Runx3 and Prdm1 expression. The markers re-
ported here that distinguish CD4+ T cells with CTL potential
from Th1 cells will be valuable in determining the transcriptional
and phenotypic stability of CD4+ CTLs, or interconversion to a
Th1 phenotype, in longitudinal cell-fate studies.
Another defining characteristic of CD4+ CTLs that distin-
guishes them from other Th subsets is the acquisition of CD8+
lineage-related features. Our analysis confirmed the relative
loss of Zbtb7b expression (encoding ThPOK) and acquisition of
Runx3 expression, considered responsible for the reprogram-
ming of CD4+ CTLs (Mucida et al., 2013; Reis et al., 2013). How-
ever, despite acquiring Runx3 expression under the conditions
we have examined, CD4+ CTLs did not express other CD8+ line-
age-related genes, such as Cd8a or Crtam, previously observed
in CD4+ CTLs in other conditions (Mucida et al., 2013; Reis et al.,
2013; Takeuchi et al., 2016). It is possible that acquisition of CD8+
lineage-related characteristics is not as extensive in splenicCD4+
CTLs as in intestine intraepithelial CD4+ CTLs. It is also possible
that further reprogramming of CD4+ CTLs requires longer anti-
genic stimulation than the 7 days we have examined here.1580 Cell Reports 17, 1571–1583, November 1, 2016Our ability to contrast the global transcriptional profile of
Gzmb+ CD4+ T cells against that of other CD4+ T cells revealed
a principal feature of CD4+ CTL differentiation; namely, antago-
nism by the Tfh program. Indeed, loss of Tcf7 and Lef1 expres-
sion distinguished CD4+ CTL from other CD4+ T cell subsets,
including Ifng+ Th1 cells. TCF-1 (encoded by Tcf7) and its homo-
log, LEF-1, have been recently demonstrated to coordinate Tfh
differentiation partly by enhancing Bcl6 expression during
LCMV infection (Choi et al., 2015; Wu et al., 2015; Xu et al.,
2015). Interestingly, Tcf7 and Lef1 gene deletion in CD4+
T cells in two of these studies promoted transcriptional features
of Th1 cells, as well as of CD4+ CTLs, includingGzmb expression
(Choi et al., 2015; Xu et al., 2015). The acquisition of CTL-related
characteristics by Tcf7-deficient CD4+ T cells in these population
studies was interpreted as part of enhanced Th1 responses
(Choi et al., 2015; Xu et al., 2015). Our single-cell analysis clearly
demonstrated that the blocking of Tfh differentiation can pro-
mote Th1 and CTL differentiation of distinct cells. Not only
were Th1 cells and CD4+ CTLs transcriptionally separable, but
they were also induced to different degrees in response to
different infections. This was exemplified by retroviral infection,
whereBcl6 deficiency promoted Th1, but not CTL, differentiation
of CD4+ T cells and adenoviral vaccination, where Bcl6 defi-
ciency unleashed specifically CTL differentiation.
Antagonism between the Tfh and CD4+ CTL programs is also
supported by the contrasting expression of Blimp1 (encoded by
Prdm1). Blimp1 suppresses both Bcl6 and Tcf7 expression and
is, in turn, negatively regulated by Bcl6 and TCF-1 (Choi et al.,
2015; Wu et al., 2015; Xu et al., 2015). Previous studies demon-
strated defective GzmB expression by Blimp1-deficient CD4+
T cells, whereas Blimp1 overexpression enhances CD4+ CTL dif-
ferentiation (Gong and Malek, 2007; Hua et al., 2013). These
studies suggest that CD4+ CTL differentiation requires Blimp1,
which is thought to enhance T-bet binding to the promoters of
CTL-related genes, including Gzmb (Gong and Malek, 2007;
Hua et al., 2013). Although Blimp1 expression, in combination
with loss of TCF-1, was shown here to be a unique characteristic
of CD4+ CTLs, Blimp1 can also be expressed highly by other Th
subsets, and its expression alone is not sufficient to drive CD4+
CTL development in our experimental systems. For example,
Bcl6 deficiency induced significantly elevated expression of
both Prdm1 and Tbx21 in CD4+ T cells responding to FV infec-
tion, but it did not enhance CTL differentiation, arguing that
Blimp1 may be necessary, but not sufficient, to drive the CTL
program in CD4+ T cells.
Retroviral infection was particularly ineffective at inducing CTL
differentiation in responding CD4+ T cells. This apparent defect
was also observed when Tfh differentiation was precluded by
deletion of Bcl6, suggesting additional blocks in CD4+ CTL
differentiation. Our present findings add the dimension of
intrinsic regulation of CD4+ CTL differentiation by the inhibitory
receptors PD-1 and LAG3, induced in response, specifically, to
retroviral infection. These receptors represented an additional
layer of regulation, which prevented Bcl6-deficient CD4+
T cells acquiring CTL characteristics. Indeed, CD4+CTL differen-
tiation in FV infection required the combination of Bcl6 deletion
and PD-1 and LAG3 blockade. In addition to PD-1 and LAG3,
CD4+ CTLs were also characterized by expression of the
inhibitory receptor Tim-3 (encoded by Havcr2), which was, in
fact, entirely restricted to Gzmb+ cells. The precise cause of
the highly elevated expression of inhibitory receptors in virus-
specific effector CD4+ T cells, particularly, in CD4+ CTLs,
specifically in response to retroviral infection, remains poorly
understood. Notably, GzmB production has been previously de-
tected in CD4+ T cells responding to FV or FV-induced FBL-3
cells, when Treg cells and CD8+ T cells were depleted (Akhmet-
zyanova et al., 2013; Manzke et al., 2013), suggesting extrinsic
regulation. These data imply that both extrinsic regulation, in
the form of Treg cells, and intrinsic regulation, in the form of
inhibitory receptors in effector T cells, are effectively exploited
by retroviruses.
Although incompletely understood, the induction of inhibitory
receptors in virus-specific CD4+ T cells during FV infection re-
quires cognate interaction with B cells (Ploquin et al., 2011).
Expression of PD-1 in virus-specific CD4+ T cells, for example,
is significantly reduced in the absence of B cell antigen presen-
tation during FV infection (Ploquin et al., 2011) or endogenous
antigen expression (Han et al., 2010). In keeping with these ob-
servations, B cell deficiency also enhanced CD4+ CTL differenti-
ation in this study. These findings are entirely consistent with a
critical role for B cells in deciding the balance between Tfh and
CTL differentiation of interacting CD4+ T cells. B cells play a
well-described role in stabilizing the Tfh program (Crotty, 2014;
Vinuesa et al., 2016), and, together with inducing PD-1 expres-
sion in CD4+ T cells, they inhibit CD4+ CTL differentiation.
Such a role for B cells would ensure efficient antibody production
at the expense of CD4+ T cell-mediated immunity. Indeed,
B cells inhibit antibody-independent CD4+ T cell-mediated pro-
tection against tumors (Qin et al., 1998) or FV-induced erythro-
blastosis (Pike et al., 2009).
A critical influence of the type of antigen-presenting cell on Tfh
and CTL differentiation may also underlie the difference in the
efficiency with which distinct viruses or viral vaccines elicit either
Tfh or CD4+ CTLs. Elucidation of the role of distinct antigen-
presenting cell types in this process may hold the key to both
understanding and controlling the balance between Tfh and
CD4+ CTLs.
Overall, using single-cell analysis, our study revealed the tran-
scriptional signature of Gzmb-expressing CD4+ T cells. Their
unique transcriptional features not only support the notion of a
distinguishable CD4+ CTL subset but also provide markers for
future identification and further longitudinal study of CD4+
CTLs. Additionally, regulation of the CD4+ CTL program by the
TCF-1-Bcl6 axis, B cells, and inhibitory receptors, offers a
means for manipulating the cytotoxic activity of CD4+ T cells in
health and disease.EXPERIMENTAL PROCEDURES
Mice
Inbred B6 and CD45.1+ congenic B6 (B6.SJL-Ptprca Pep3b/BoyJ) mice,
TCRb-transgenic EF4.1 mice (Antunes et al., 2008), TCRab doubly transgenic
EVa2 mice (Merkenschlager et al., 2016), Rag1-deficient (Rag1/) mice
(Mombaerts et al., 1992), B cell-receptor-deficient (Ighm/) mice (Kitamura
et al., 1991), mice with an activatable YFP gene targeted into the Gt(ROSA)
26Sor (R26) locus (Srinivas et al., 2001), mice with a targeted insertion of
Cre recombinase into the Tnfrsf4 locus (Klinger et al., 2009) (Tnfrsf4Cre), micewith a conditional Bcl6 allele (Kaji et al., 2012) (Bcl6fl), endogenous ecotropic
murine-leukemia-virus-deficient (Emv2/) mice (Young et al., 2012), mice
with a targeted insertion of GFP into the Prdm1 locus (Kallies et al., 2009)
(Blimp1-GPF), and mice with a targeted insertion of tdTomato fluorescent pro-
tein into the Gzmb locus (Mouchacca et al., 2013) (GzmB-tdTomato) were all
on the B6 genetic background and were maintained at the Francis Crick Insti-
tute’s animal facilities. All animal experiments were approved by the ethical
committee of the Francis Crick Institute and were conducted according to
local guidelines and UK Home Office regulations under the Animals (Scientific
Procedures Act) 1986 (ASPA).
Retroviral Infection and Immunization
Details of infections, immunizations, and other in vivo treatments can be found
in the Supplemental Information.
T Cell Purification, Adoptive Transfer, and Recovery
Single-cell suspensions were prepared from the spleens and lymph nodes
of donor CD45.1+ or CD45.2+ EF4.1 mice or CD45.2+ EVa2 mice, and
CD4+ T cells were enriched using immunomagnetic positive selection
(StemCell Technologies) at >90% purity. A total of 1 3 106 EF4.1 CD4+
T cells or 13 105 EVa2 CD4+ T cells was injected into CD45.1+CD45.2+ recip-
ients via the tail vein. Env-reactive donor CD4+ T cells were purified (>98%
purity) from the spleens of recipient mice by cell sorting, performed on MoFlo
cell sorters (Dako-Cytomation).
Flow Cytometry
Single-cell suspensions were stained with directly conjugated antibodies to
surface markers obtained from eBiosciences, CALTAG/Invitrogen, BD Biosci-
ences, or BioLegend.
For intracellular detection of GzmB, spleen cell suspensionswere stimulated
for 4 hr with phorbol 14,13 dybutirate (PdBu) and ionomycin (both at
500 ng/ml), in the presence of monensin (2 mg/ml). Cells were then stained
for surface antigen and washed; after this step, they were fixed and permea-
bilized using an anti-mouse/rat FoxP3 staining kit (eBioscience), according
to the manufacturer’s instructions. After an additional wash step, cells were
stained for intracellular GzmB with Alexa Fluor 647- or FITC (fluorescein iso-
thiocyanate)-conjugated anti-human/mouse GzmB antibodies (clone GB11,
Biolegend) and phycoerythrin (PE)-conjugated anti-mouse IFN-g antibodies
(clone XMG1.2, eBioscience). Multi-color cytometry was performed on Canto
II or LSRFortessa X-20 flow cytometers (both from BD Biosciences) and
analyzed with FlowJo v10 (Tree Star).
Cytotoxicity Assays
Details of in vitro and in vivo cytotoxicity assays can be found in the Supple-
mental Information.
PCR-Based Expression Profiling
Expression of selected genes was quantified in env-reactive CD4+ T cells by
real-time qRT-PCR. The indicated CD4+ T cell populations were purified by
cell sorting, and RNA was isolated using the QIAcube (QIAGEN). Synthesis
of cDNA was carried out with the High Capacity Reverse Transcription Kit
(Applied Biosystems) with an added RNase inhibitor (Promega Biosciences).
A final clean-up was performed with the QIAquick PCR Purification Kit
(QIAGEN). Purified cDNA was then used as template for the quantitation of
the indicated genes using gene-specific primers (Eurofins MWG Operon)
(Table S2). Values were normalized and plotted according to the expression
of Hprt in the same samples, using a DCT method.
Single-Cell RNA Sequencing
Env-reactive CD4+ T cells from the indicated recipient mice were purified by
cell sorting. A detailed description of subsequent single-cell RNA sequencing
can be found in the Supplemental Information.
Statistical Analyses
Statistical comparisons were made using SigmaPlot 12.0 (Systat Software).
Parametric comparisons of normally distributed values that satisfied the vari-
ance criteria were made by unpaired Student’s t tests or one-way ANOVAs.Cell Reports 17, 1571–1583, November 1, 2016 1581
Data that did not pass the variance test were compared with non-parametric
two-tailed Mann-Whitney rank sum tests or ANOVA on ranks tests. Hierarchi-
cal clustering and heatmap production was performed with Qlucore Omics
Explorer (Qlucore).
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